New Releases from NCBI BookshelfNintedanib for treating idiopathic pulmonary fibrosis when forced vital capacity is above 80% predicted.Nintedanib for treating idiopathic pulmonary fibrosis when forced vital capacity is above 80% predicted.
Post Content